# A Trial to Assess How Centanafadine Interacts With Stimulants in the Body

> **NCT07314333** · PHASE1 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 40 (actual)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** Centanafadine
- **DRUG:** Methylphenidate
- **DRUG:** Lisdexamfetamine

## Key facts

- **NCT ID:** NCT07314333
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-02-05
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-04-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07314333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07314333, "A Trial to Assess How Centanafadine Interacts With Stimulants in the Body". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07314333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*